Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Snap-on Inc Director's Dealing 2024

Aug 13, 2024

30335_dirs_2024-08-12_87d856ae-c258-4976-aa65-a4f1d7df7fe8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Snap-on Inc (SNA)
CIK: 0000091440
Period of Report: 2024-08-12

Reporting Person: PINCHUK NICHOLAS T (Director, Chairman, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-08-12 Common Stock M 32500 $144.69 Acquired 783164.4829 Direct
2024-08-12 Common Stock S 3741 $267.5577 Disposed 779423.4829 Direct
2024-08-12 Common Stock S 9856 $268.6507 Disposed 769567.4829 Direct
2024-08-12 Common Stock S 9515 $269.4575 Disposed 760052.4829 Direct
2024-08-12 Common Stock S 333 $270.0492 Disposed 759719.4829 Direct
2024-08-12 Common Stock S 700 $273.20 Disposed 759019.4829 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-08-12 Stock Option (Right to Buy) $144.69 M 32500 Disposed 2025-02-12 Common Stock (32500) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 837.4886 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $138.03 2026-02-11 Common Stock (135000) 135000 Direct
Stock Option (Right to Buy) $168.70 2027-02-09 Common Stock (135000) 135000 Direct
Stock Option (Right to Buy) $161.18 2028-02-15 Common Stock (92288) 92288 Direct
Stock Option (Right to Buy) $155.92 2029-02-14 Common Stock (83059) 83059 Direct
Stock Option (Right to Buy) $155.34 2030-02-13 Common Stock (83059) 83059 Direct
Stock Option (Right to Buy) $189.89 2031-02-11 Common Stock (40687) 40687 Direct
Stock Option (Right to Buy) $211.67 2032-02-10 Common Stock (32286) 32286 Direct
Stock Option (Right to Buy) $249.26 2033-02-09 Common Stock (24295) 24295 Direct
Stock Option (Right to Buy) $269.00 2034-02-15 Common Stock (23710) 23710 Direct
Restricted Stock Units $ 2025-02-10 Common Stock (5519) 5519 Direct
Restricted Stock Units $ 2026-02-09 Common Stock (5549) 5549 Direct
Restricted Stock Units $ 2027-02-15 Common Stock (5114) 5114 Direct
Performance Units $ Common Stock (16558) 16558 Direct
Performance Units $ Common Stock (16645) 16645 Direct
Performance Units $ Common Stock (15340) 15340 Direct
Deferred Stock Units $ Common Stock (25233.7497) 25233.7497 Direct

Footnotes

F1: The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on October 26, 2023.

F2: Includes 1.5428 shares acquired under a dividend reinvestment plan.

F3: This transaction was executed in multiple trades at prices ranging from $267.00 to $267.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

F4: This transaction was executed in multiple trades at prices ranging from $268.01 to $269.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

F5: This transaction was executed in multiple trades at prices ranging from $269.01 to $269.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

F6: This transaction was executed in multiple trades at prices ranging from $270.01 to $270.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

F7: This information is based on a plan statement dated June 30, 2024.

F8: Option fully vested.

F9: Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on October 26, 2023.

F10: Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column.

F11: 1 for 1.

F12: The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment.

F13: If the Company achieves certain goals over the 2022-2024 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.

F14: If the Company achieves certain goals over the 2023-2025 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.

F15: If the Company achieves certain goals over the 2024-2026 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.

F16: Payment will be made in accordance with the reporting person's deferral election, death, disability or termination of employment.